Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II

Molecular Genetics and Metabolism

Volumn 98, Issue 4, 2009, Pages 406-411

  Wang, Raymond Y ^a   Cambray Forker, Elizabeth Jane ^b   Ohanian, Kirk ^b   Karlin, David S ^b   Covault, Kelly K ^a   Schwartz, Philip H ^c,d   Abdenur, Jose E ^a  

^a Pediatric Subspecialty Faculty   (United States)

^b ST JOSEPH HOSPITAL   (United States)

^c Children's Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Enzyme replacement therapy; Hunter syndrome; Hurler syndrome; Magnetic resonance imaging; Mucopolysaccharidosis; Outcomes; Stem cell transplant

Indexed keywords

CREATININE; ENALAPRIL; GAG PROTEIN; GLYCOSAMINOGLYCAN; LARONIDASE; LEVO IDURONIDASE;

ADENOIDECTOMY; AGGRESSION; AORTA VALVE REGURGITATION; ARTICLE; ATAXIA; ATTENTION DISTURBANCE; BLOOD BRAIN BARRIER; CARPAL TUNNEL SYNDROME; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CORPUS CALLOSUM; CREATININE BLOOD LEVEL; DIAPHORESIS; DISEASE SEVERITY; DYSARTHRIA; ENURESIS; ENZYME ACTIVITY; ENZYME REPLACEMENT; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMIZYGOSITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; HYDROCELE; INFANT; JOINT MOBILITY; LETHARGY; MALE; MENTAL DEFICIENCY; MITRAL VALVE REGURGITATION; MUTATIONAL ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS MEDIA; PERCEPTION DEAFNESS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP APNEA SYNDROME; TONSILLECTOMY; TRICUSPID VALVE DISEASE; TYMPANOSTOMY TUBE; VALGUS KNEE; VERTEBRAL CANAL STENOSIS;

BRAIN MAPPING; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSIS I; MUCOPOLYSACCHARIDOSIS II;

EID: 70350618788     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.07.015     Document Type: Article

References (27)

1. Malm G., Lund A.M., Månsson J.E., and Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr. 97 (2008) 1577-1581
2. Baehner F., Schmiedeskamp C., Krummenauer F., Miebach E., Bajbouj M., Whybra C., Kohlschütter A., Kampmann C., and Beck M. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J. Inherit. Metab. Dis. 28 (2005) 1011-1017
3. Murata R., Nakajima S., Tanaka A., Miyagi N., Matsuoka O., Kogame S., and Inoue Y. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am. J. Neuroradiol. 10 (1989) 1165-1170
4. Shimoda-Matsubayashi S., Kuru Y., Sumie H., Ito T., Hattori N., Okuma Y., and Mizuno Y. MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 32 (1990) 328-330
5. Lee C., Dineen T.E., Brack M., Kirsch J.E., and Runge V.M. The mucopolysaccharidoses: characterization by cranial MR imaging. Am. J. Neuroradiol. 14 (1993) 1285-1292
6. Gabrielli O., Polonara G., Regnicolo L., Petroni V., Scarabino T., Coppa G.V., and Salvolini U. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am. J. Med. Genet. A 15 (2004) 224-231
7. Matheus M.G., Castillo M., Smith J.K., Armao D., Towle D., and Muenzer J. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46 (2004) 666-672
8. Parsons V.J., Hughes D.G., and Wraith J.E. Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin. Radiol. 51 (1996) 719-723
9. Barone R., Parano E., Trifiletti R.R., Fiumara A., and Pavone P. White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: characterization by MRI. J. Neurol. Sci. 195 (2002) 171-175
10. Vedolin L., Schwartz I.V., Komlos M., Schuch A., Puga A.C., Pinto L.L., Pires A.P., and Giugliani R. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am. J. Neuroradiol. 28 (2007) 1029-1033
11. Vedolin L., Schwartz I.V., Komlos M., Schuch A., Azevedo A.C., Vieira T., Maeda F.K., Marques da Silva A.M., and Giugliani R. Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology 69 (2007) 917-924
12. Kakkis E.D., McEntee M.F., Schmidtchen A., Neufeld E.F., Ward D.A., Gompf R.E., Kania S., Bedolla C., Chien S.L., and Shull R.M. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I. Biochem. Mol. Med. 58 (1996) 156-167
13. Miebach E. Enzyme replacement therapy in mucopolysaccharidosis type I. Acta Paediatr. Suppl. 94 (2005) 58-60
14. Staba S.L., Escolar M.L., Poe M., Kim Y., Martin P.L., Szabolcs P., Allison-Thacker J., Wood S., Wenger D.A., Rubinstein P., Hopwood J.J., Krivit W., and Kurtzberg J. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N. Engl. J. Med. 350 (2004) 1960-1969
15. Vellodi A., Young E., Cooper A., Lidchi V., Winchester B., and Wraith J.E. Long-term follow-up following bone marrow transplantation for Hunter disease. J. Inherit. Metab. Dis. 22 (1999) 638-648
16. Guffon N., Bertrand Y., Forest I., Fouilhoux A., and Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J. Pediatr. 154 (2009) 733-737
17. Seto T., Kono K., Morimoto K., Inoue Y., Shintaku H., Hattori H., Matsuoka O., Yamano T., and Tanaka A. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann. Neurol. 50 (2001) 79-92
18. Takahashi Y., Sukegawa K., Aoki M., Ito A., Suzuki K., Sakaguchi H., Watanabe M., Isogai K., Mizuno S., Hoshi H., Kuwata K., Tomatsu S., Kato S., Ito T., Kondo N., and Orii T. Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr. Res. 49 (2001) 349-355
19. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., and Holtzman D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295 (2002) 2264-2267
20. Lemere C.A., Spooner E.T., LaFrancois J., Malester B., Mori C., Leverone J.F., Matsuoka Y., Taylor J.W., DeMattos R.B., Holtzman D.M., Clements J.D., Selkoe D.J., and Duff K.E. Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice. Neurobiol. Dis. 14 (2003) 10-18
21. Begley D.J., Pontikis C.C., and Scarpa M. Lysosomal storage diseases and the blood-brain barrier. Curr. Pharm. Des. 14 (2008) 1566-1580
22. Wu Y.P., and Proia R.L. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc. Natl. Acad. Sci. USA 101 (2004) 8425-8430
23. Vogler C., Levy B., Grubb J.H., Galvin N., Tan Y., Kakkis E., Pavloff N., and Sly W.S. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc. Natl. Acad. Sci. USA 102 (2005) 14777-14782
24. Grubb J.H., Vogler C., Levy B., Galvin N., Tan Y., and Sly W.S. Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. Proc. Natl. Acad. Sci. USA 105 (2008) 2616-2621
25. Blanz J., Stroobants S., Lüllmann-Rauch R., Morelle W., Lüdemann M., D'Hooge R., Reuterwall H., Michalski J.C., Fogh J., Andersson C., and Saftig P. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice. Hum. Mol. Genet. 17 (2008) 3437-3445
26. Urayama A., Grubb J.H., Sly W.S., and Banks W.A. Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse. Mol. Ther. 16 (2008) 1261-1266
27. Matzner U., Lüllmann-Rauch R., Stroobants S., Andersson C., Weigelt C., Eistrup C., Fogh J., D'Hooge R., and Gieselmann V. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol. Ther. 17 (2009) 600-606